Partenariat entre l’AP-HP et le laboratoire CT-RS pour la prise en charge des maladies rares du foie : une ASMR 1 pour ORPHACOL® Le laboratoire pharmaceutique Cell Therapies Research & Services (CT-RS) obtient le plus haut niveau de l’Amélioration du Service Médical Rendu (ASMR 1[1]) de la commission de transparence de la Haute Autorité de Santé […]
Mots clés | industrials partnerships
Highest rating for clinical benefit from the French health authorities to Orphacol®, a treatment of rare liver diseases. Successful Transfer from AP-HP to Laboratoires CTRS
05/03/2014
Highest rating for clinical benefit from the French health authorities to Orphacol®,a treatment of rare liver diseases. Successful Transfer from AP-HP to Laboratoires CTRS The pharmaceutical company, Laboratoires CTRS, received the highest rating for improvement in medical benefit (Amélioration du Service Médical Rendu, ASMR 1[1]) from the French National Authority for Health’s Transparency Commission for […]
Paris Hospitals’ technology transfer arm, OTTLIV, holds its 9th APinnov annual conference
02/07/2012
Conference takes place July 2, 2012 at the Paris Chamber of Commerce and Industry, and will mark the launch and award of the first “Innovation Trophies” for outstanding projects Paris, June 27, 2012 – OTTLIV, the technology transfer arm of one of the world’s leading public health establishments, AP-HP (Assistance Publique-Hôpitaux de Paris), will hold […]
